New month, new opportunities! Why not connect with one of our global talent acquisition specialists today and discover how we can help you discover an exciting new role? Visit our jobs page and explore our website to learn more about our talented team. https://lnkd.in/ePKhSeEP #MetricBio #NewRoles #Opportunities #CurrentRoles
About us
Utilizing our expertise to provide recruitment solutions to some of the worlds most cutting-edge companies in MedTech and Life Science. Our world-leading team of expert’s passion lies in deliver cutting edge talent solutions to visionary clients, positively impacting human health within a variety of specialisms including: - Biotech - CDMO - CRO - MedTech New York | London | Florida | Nottingham
- Website
-
http://www.metric-search.com
External link for Metric Bio
- Industry
- Staffing and Recruiting
- Company size
- 51-200 employees
- Headquarters
- New York
- Type
- Privately Held
- Specialties
- Biotech , Genomics, Lab Automation, Cell & Gene Therapy, Cellular Agriculture, CDMO, Biologics, Drug Products, API, CRO, Pre-Clinical, Clinical, E-Clinical, Clinical Trial Supply, Drug Discovery, Digital Health, HealthTech, Artificial Intelligence, SaaS, Telemedicine, MedTech, Neurotech, FemTech, Cardiovascular, Medical Imagine & AI, Surgical Robotics, Orthopaedic and Spine, Pharma, and Molecular Diagnostics
Locations
-
Primary
New York, US
-
Fort Lauderdale, US
-
London, GB
-
Nottingham, GB
Employees at Metric Bio
Updates
-
We’re always on the lookout for talented individuals wanting a fresh start working alongside our industry-leading partners. Our Group Business Manager, James Howsam, specializes in the CRO market, successfully placing talented, career-driven individuals within the commercial drug discovery and development space. Read below about a handful of James’ recently placed roles and reach out to see how he can help you in your career journey. https://lnkd.in/e7H_-zXJ #MetricBio #RecentRoles #CRO #DrugDescovery
-
-
Metric Bio is home to some of the world's best recruiters in the Life Science and MedTech industry. As such they embed themselves within their markets, becoming specialists in their own niche areas. Business Development Executive Anastasia Ward, is a global recruiter in the CDMO market – read her recent article on the collaboration of Twist Bioscience and bitBiome, Inc. as they join forces to revolutionize enzyme screening for the pharma industry below, and be sure to share your thoughts. https://lnkd.in/e_emkMyq #MetricBio #Recruitment #CDMO
-
Our team of experts at Metric Bio offer a precise and efficient service focused on building high-performing teams and long-term partnerships with clients. Our Senior Business Development Lead and Employee of the Period, Caitlin James, exemplifies this commitment. She ensures a smooth hiring process while finding the best possible fit for our partners in the MedTech market. Don't just take our word for it, read about Nick Wessinger’s experience with Caitlin James, and visit her web page to learn more about her impressive track record. https://lnkd.in/ed52_4EK #MetricBio #Recruitment #Testimony #EmployeeOfThePeriod #MedTech
-
-
Maulik Mukeshbhai Patel, a leading biopharmaceutical expert, recently highlighted, "The future is already here — it's just not evenly distributed." This insight captures AI's transformative impact on the pharmaceutical industry. Traditionally, drug development is slow and costly, but AI promises to speed up discovery and reduce costs. In his article, "Unveiling the Future of Life Sciences: Advances in Cell and Molecular Biology and the Role of AI in Drug Discovery," Patel shows how AI is revolutionizing drug development by cutting time and effort, benefiting patients with faster delivery of new therapies. While challenges like data biases and high initial costs remain, Patel remains optimistic. He envisions AI-driven innovations leading to safer, more effective, and accessible treatments. The future of medicine is here, and AI is at the forefront of this exciting transformation. Read more below on Patel’s AI-powered discoveries. https://lnkd.in/er9Q3R4F #MetricBio #AI #DrugDevelopment #Pharmaceuticals #Innovation #FutureOfMedicine #Healthcare
Behind the Breakthrough: AI-Powered Strategies Speeding Up Drug Development
techtimes.com
-
Want to stay updated on all things Radiology? Then subscribe to Radiology Rundown. Our radiology specialist, Billy Williams, is fully embedded in the radiology and medical imagining market, providing world-leading talent solutions alongside insights into the sector. From FDA approvals and funding updates, to new partnerships, Billy provides a comprehensive range of information to keep you current with the latest developments in radiology. Subscribe below - https://lnkd.in/eVqf9gdz #MetricBio #Radiology #RadiologyRundown #MedicalImaging
Delighted to share the first edition of The Radiology Rundown, powered by Metric Bio. I've been recruiting to the Radiology space for over 7 years now, speaking to leaders in our industry every day and sharing news and updates from the market. This newsletter is the place to find those updates, all in one place, every month. Keeping you up to date with industry trends, FDA approvals, funding announcements and the hottest opportunities. So please take a look, subscribe and share with me anything you would like included in next month's edition. #Radiology #MedicalImaging #RadiologyAI #Pathology #RSNA
The Radiology Rundown - July 24
Billy Williams on LinkedIn
-
Associate Professor Giuseppe M. J. Barca from the University of Melbourne has led a team to achieve a historic milestone: the first quantum simulation of biological systems at a scale necessary to accurately model drug performance. Using the Frontier supercomputer at Oak Ridge National Laboratory in Tennessee, the team has developed software that can accurately predict the chemical reactions and physical properties of molecular systems, comprising of up to hundreds of thousands of atoms—delivering highly precise predictions of molecular behavior and setting a new benchmark in computational chemistry. This project, in collaboration with Oak Ridge National Laboratory, AMD, and deep-tech startup QDX, allows for unprecedented precision in simulating drug behaviour. “We can now observe not just the movement of a drug but also its quantum mechanical properties. This is vital for assessing drug viability and designing new treatments,” said Associate Professor Barca. This breakthrough is crucial as over 80% of disease-causing proteins remain untreatable with current drugs. By expanding our computational toolset, this technology promises faster, more accurate drug discovery and the potential for new treatments. Read more below about this advancement. https://lnkd.in/g3YZ46g2 #MetricBio #Recruitment #DrugDiscovery #FrontierSupercomputer #Innovation #MedicalResearch
High-performance computing and quantum chemistry advances drug discovery
phys.org
-
Metric Bio is a hub for world-class talent acquisition specialists, dedicated to matching the right people with the best suited roles. Our team takes pride in building strong partnerships and delivering top talent solutions through our specialized industry knowledge. Cell and Gene CDMO specialist Sam McElroy exemplifies the exceptional talent we have at Metric Bio, consistently showcasing his expertize. Read below about Heather Sheely, SHRM-CP's experience with Sam McElroy and visit his webpage to learn how Sam can assist you with your hiring needs. https://lnkd.in/eAGh-U3z #MetricBio #Testimony #CDMO
-
Novo Holdings, a leading life science investor, has led a $105 million financing in Magenta Medical Ltd., developers of the Elevate System, the world’s smallest heart pump. This funding supports Magenta’s US clinical programs, targeting FDA approval for the Elevate System in patients undergoing high-risk percutaneous coronary interventions (HR-PCI). The Elevate System, designed for mechanical circulatory support (MCS), offers a minimally invasive solution for patients with severe cardiovascular conditions, earning FDA's Breakthrough Device Designation. Eric Snyder from Novo Holdings joins Magenta’s Board of Directors, expressing confidence in the technology's potential to transform patient care. Magenta Medical Ltd.'s CEO Dr. David Israeli welcomes this partnership, emphasizing the alignment with other top MedTech investors to advance their mission. With a pivotal US study on the horizon, Magenta is poised to make significant strides in the MCS field. Click the link below to learn more about the implications of this investment. https://lnkd.in/eaJWNQbz #MetricBio #MedicalInnovation #HeartHealth #MCS #MagentaMedical #NovoHoldings
Novo Holdings leads $105 million financing of Magenta Medical to support FDA approval for world’s smallest heart pump
novoholdings.dk
-
At Metric Bio, we pride ourselves on being a global brand. We offer career opportunities around the world with leading companies, providing you with a seamless career journey. Why not see for yourself? Explore some our current opportunities and visit our jobs page to learn more. https://lnkd.in/eWEBHaFG #MetricBio #CurrentRoles #Recruitment
-